InvestorsHub Logo

Pharma Sleuth

08/25/23 3:30 PM

#386228 RE: jour_trader #386225

Jour trader posts this on Yahoo but not allowed to do it here?

There’s little debt and will be paid off by next year, per last cc. Been CFP for little while. Excess profits going back into business, namely R&D & capex. Recently mentioned need for another mfg facility within next 2-3 years. They aren’t bursting their current plant out of the seems, which signals they have high expectations for at least one if not multiple approval of larger generics. Deal with Prasco to be authorized generic starting 1/1 for Adderall will be one of many game changers. Lots of good news expected rest of year.

A repurchase program was mentioned on last call. With successful launch of larger drug & auth generic, there will be nice amount of excess cash to execute repurchase and pay off debt.